A-SPINE Asia Co., Ltd. (TPEX:6758)
Taiwan · Delayed Price · Currency is TWD 29.10
0.00 (0.00%)
Aug 19, 2026, 10:49 AM CST
A-SPINE Asia Market Cap
A-SPINE Asia has a market cap or net worth of 392.01 million as of August 18, 2026. Its market cap has decreased by -30.71% in one year.
Market Cap
392.01M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
29.10
ChartMarket Cap Chart
Since January 2, 2020, A-SPINE Asia's market cap has decreased from 1.20B to 392.01M, a decrease of -67.30%. That is a compound annual growth rate of -15.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 392.01M | -26.33% |
| Dec 31, 2025 | 532.11M | -1.00% |
| Dec 30, 2024 | 537.49M | 2.57% |
| Dec 29, 2023 | 524.02M | 2.37% |
| Dec 30, 2022 | 511.90M | -19.23% |
| Dec 10, 2021 | 633.81M | -18.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wiltrom | 999.18M |
| Diamond Biotechnology | 990.64M |
| Cowealth Medical Holding | 925.54M |
| Radiant Innovation | 785.71M |
| PlexBio | 748.35M |
| Carilex Medical | 652.77M |
| AmCad BioMed | 649.16M |
| Health & Life | 519.11M |